Log in to save to my catalogue

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1989588988

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

About this item

Full title

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2018-01, Vol.378 (3), p.230-240

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

The addition of HIPEC with cisplatin to cytoreductive surgery in stage III ovarian cancer resulted in recurrence-free survival that was longer by 3.5 months and overall survival that was longer by nearly a year than surgery alone and did not result in higher rates of side effects.

Alternative Titles

Full title

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1989588988

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1989588988

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1708618

How to access this item